Unknown PHASE3 INTERVENTIONAL 2-arm NCT03219580

The Role of 5-Fluorouracil in Post-Operative Scar Formation Following Direct Brow Ptosis Repair

Sponsor: Eyelid and Facial Consultants

Interventions 5-Fluorouracil Normal Saline Flush, 0.9% Injectable Solution

Updated 7 times since 2017 Last updated: Jul 23, 2018 Started: May 20, 2017 Primary completion: Apr 30, 2020 Completion: Aug 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Brow Ptosis and Facial Scarring, this trial is ongoing. The trial is conducted by Eyelid and Facial Consultants and has accumulated 7 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Sep 2020 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Enrolling By Invitation → Unknown Status
Aug 2018 — Sep 2020 [monthly]

Enrolling By Invitation PHASE3

▶ Show 2 earlier versions

Jun 2018 — Aug 2018 [monthly]

Enrolling By Invitation PHASE3
Aug 2017 — Jun 2018 [monthly]

Enrolling By Invitation PHASE3

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eyelid and Facial Consultants
Ochsner Health System

Data source: Eyelid and Facial Consultants

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houma, United States
• New Orleans, United States